Medication Overuse Headache in Children and Adolescents
Abstract Medication overuse headache can be described as a chronic headache, presenting 15 or more days per month, in a patient who abuses symptomatic drugs. It has been called an unrecognized epidemic; this is in part true for adults, but is certainly so for children and adolescents. This paper rev...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Chiappedi, Matteo [verfasserIn] Balottin, Umberto [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2014 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
Enthalten in: Current Review of Pain - Current Medicine Group, 1998, 18(2014), 4 vom: 13. Feb. |
|---|---|
| Übergeordnetes Werk: |
volume:18 ; year:2014 ; number:4 ; day:13 ; month:02 |
| Links: |
|---|
| DOI / URN: |
10.1007/s11916-014-0404-9 |
|---|
| Katalog-ID: |
SPR023009993 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR023009993 | ||
| 003 | DE-627 | ||
| 005 | 20230520013011.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201006s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11916-014-0404-9 |2 doi | |
| 035 | |a (DE-627)SPR023009993 | ||
| 035 | |a (SPR)s11916-014-0404-9-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chiappedi, Matteo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Medication Overuse Headache in Children and Adolescents |
| 264 | 1 | |c 2014 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Medication overuse headache can be described as a chronic headache, presenting 15 or more days per month, in a patient who abuses symptomatic drugs. It has been called an unrecognized epidemic; this is in part true for adults, but is certainly so for children and adolescents. This paper reviews existing data concerning epidemiology, etiopathogenesis and treatment options, with a focus on pediatric age. This leads to evidence of a relevant number of still unanswered questions and some possible strategies to help children and adolescents with this disabling disorder. | ||
| 650 | 4 | |a Medication overuse headache |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Child |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Adolescent |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Chronic headache |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Epidemiology |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Etiopathogenesis |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Treatment |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Balottin, Umberto |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current Review of Pain |d Current Medicine Group, 1998 |g 18(2014), 4 vom: 13. Feb. |w (DE-627)SPR023001666 |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:2014 |g number:4 |g day:13 |g month:02 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s11916-014-0404-9 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_73 | ||
| 912 | |a GBV_ILN_252 | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 2014 |e 4 |b 13 |c 02 | ||
| author_variant |
m c mc u b ub |
|---|---|
| matchkey_str |
chiappedimatteobalottinumberto:2014----:eiainvrshaahicidea |
| hierarchy_sort_str |
2014 |
| publishDate |
2014 |
| allfields |
10.1007/s11916-014-0404-9 doi (DE-627)SPR023009993 (SPR)s11916-014-0404-9-e DE-627 ger DE-627 rakwb eng Chiappedi, Matteo verfasserin aut Medication Overuse Headache in Children and Adolescents 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract Medication overuse headache can be described as a chronic headache, presenting 15 or more days per month, in a patient who abuses symptomatic drugs. It has been called an unrecognized epidemic; this is in part true for adults, but is certainly so for children and adolescents. This paper reviews existing data concerning epidemiology, etiopathogenesis and treatment options, with a focus on pediatric age. This leads to evidence of a relevant number of still unanswered questions and some possible strategies to help children and adolescents with this disabling disorder. Medication overuse headache (dpeaa)DE-He213 Child (dpeaa)DE-He213 Adolescent (dpeaa)DE-He213 Chronic headache (dpeaa)DE-He213 Epidemiology (dpeaa)DE-He213 Etiopathogenesis (dpeaa)DE-He213 Treatment (dpeaa)DE-He213 Balottin, Umberto verfasserin aut Enthalten in Current Review of Pain Current Medicine Group, 1998 18(2014), 4 vom: 13. Feb. (DE-627)SPR023001666 nnns volume:18 year:2014 number:4 day:13 month:02 https://dx.doi.org/10.1007/s11916-014-0404-9 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_73 GBV_ILN_252 AR 18 2014 4 13 02 |
| spelling |
10.1007/s11916-014-0404-9 doi (DE-627)SPR023009993 (SPR)s11916-014-0404-9-e DE-627 ger DE-627 rakwb eng Chiappedi, Matteo verfasserin aut Medication Overuse Headache in Children and Adolescents 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract Medication overuse headache can be described as a chronic headache, presenting 15 or more days per month, in a patient who abuses symptomatic drugs. It has been called an unrecognized epidemic; this is in part true for adults, but is certainly so for children and adolescents. This paper reviews existing data concerning epidemiology, etiopathogenesis and treatment options, with a focus on pediatric age. This leads to evidence of a relevant number of still unanswered questions and some possible strategies to help children and adolescents with this disabling disorder. Medication overuse headache (dpeaa)DE-He213 Child (dpeaa)DE-He213 Adolescent (dpeaa)DE-He213 Chronic headache (dpeaa)DE-He213 Epidemiology (dpeaa)DE-He213 Etiopathogenesis (dpeaa)DE-He213 Treatment (dpeaa)DE-He213 Balottin, Umberto verfasserin aut Enthalten in Current Review of Pain Current Medicine Group, 1998 18(2014), 4 vom: 13. Feb. (DE-627)SPR023001666 nnns volume:18 year:2014 number:4 day:13 month:02 https://dx.doi.org/10.1007/s11916-014-0404-9 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_73 GBV_ILN_252 AR 18 2014 4 13 02 |
| allfields_unstemmed |
10.1007/s11916-014-0404-9 doi (DE-627)SPR023009993 (SPR)s11916-014-0404-9-e DE-627 ger DE-627 rakwb eng Chiappedi, Matteo verfasserin aut Medication Overuse Headache in Children and Adolescents 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract Medication overuse headache can be described as a chronic headache, presenting 15 or more days per month, in a patient who abuses symptomatic drugs. It has been called an unrecognized epidemic; this is in part true for adults, but is certainly so for children and adolescents. This paper reviews existing data concerning epidemiology, etiopathogenesis and treatment options, with a focus on pediatric age. This leads to evidence of a relevant number of still unanswered questions and some possible strategies to help children and adolescents with this disabling disorder. Medication overuse headache (dpeaa)DE-He213 Child (dpeaa)DE-He213 Adolescent (dpeaa)DE-He213 Chronic headache (dpeaa)DE-He213 Epidemiology (dpeaa)DE-He213 Etiopathogenesis (dpeaa)DE-He213 Treatment (dpeaa)DE-He213 Balottin, Umberto verfasserin aut Enthalten in Current Review of Pain Current Medicine Group, 1998 18(2014), 4 vom: 13. Feb. (DE-627)SPR023001666 nnns volume:18 year:2014 number:4 day:13 month:02 https://dx.doi.org/10.1007/s11916-014-0404-9 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_73 GBV_ILN_252 AR 18 2014 4 13 02 |
| allfieldsGer |
10.1007/s11916-014-0404-9 doi (DE-627)SPR023009993 (SPR)s11916-014-0404-9-e DE-627 ger DE-627 rakwb eng Chiappedi, Matteo verfasserin aut Medication Overuse Headache in Children and Adolescents 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract Medication overuse headache can be described as a chronic headache, presenting 15 or more days per month, in a patient who abuses symptomatic drugs. It has been called an unrecognized epidemic; this is in part true for adults, but is certainly so for children and adolescents. This paper reviews existing data concerning epidemiology, etiopathogenesis and treatment options, with a focus on pediatric age. This leads to evidence of a relevant number of still unanswered questions and some possible strategies to help children and adolescents with this disabling disorder. Medication overuse headache (dpeaa)DE-He213 Child (dpeaa)DE-He213 Adolescent (dpeaa)DE-He213 Chronic headache (dpeaa)DE-He213 Epidemiology (dpeaa)DE-He213 Etiopathogenesis (dpeaa)DE-He213 Treatment (dpeaa)DE-He213 Balottin, Umberto verfasserin aut Enthalten in Current Review of Pain Current Medicine Group, 1998 18(2014), 4 vom: 13. Feb. (DE-627)SPR023001666 nnns volume:18 year:2014 number:4 day:13 month:02 https://dx.doi.org/10.1007/s11916-014-0404-9 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_73 GBV_ILN_252 AR 18 2014 4 13 02 |
| allfieldsSound |
10.1007/s11916-014-0404-9 doi (DE-627)SPR023009993 (SPR)s11916-014-0404-9-e DE-627 ger DE-627 rakwb eng Chiappedi, Matteo verfasserin aut Medication Overuse Headache in Children and Adolescents 2014 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract Medication overuse headache can be described as a chronic headache, presenting 15 or more days per month, in a patient who abuses symptomatic drugs. It has been called an unrecognized epidemic; this is in part true for adults, but is certainly so for children and adolescents. This paper reviews existing data concerning epidemiology, etiopathogenesis and treatment options, with a focus on pediatric age. This leads to evidence of a relevant number of still unanswered questions and some possible strategies to help children and adolescents with this disabling disorder. Medication overuse headache (dpeaa)DE-He213 Child (dpeaa)DE-He213 Adolescent (dpeaa)DE-He213 Chronic headache (dpeaa)DE-He213 Epidemiology (dpeaa)DE-He213 Etiopathogenesis (dpeaa)DE-He213 Treatment (dpeaa)DE-He213 Balottin, Umberto verfasserin aut Enthalten in Current Review of Pain Current Medicine Group, 1998 18(2014), 4 vom: 13. Feb. (DE-627)SPR023001666 nnns volume:18 year:2014 number:4 day:13 month:02 https://dx.doi.org/10.1007/s11916-014-0404-9 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_73 GBV_ILN_252 AR 18 2014 4 13 02 |
| language |
English |
| source |
Enthalten in Current Review of Pain 18(2014), 4 vom: 13. Feb. volume:18 year:2014 number:4 day:13 month:02 |
| sourceStr |
Enthalten in Current Review of Pain 18(2014), 4 vom: 13. Feb. volume:18 year:2014 number:4 day:13 month:02 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Medication overuse headache Child Adolescent Chronic headache Epidemiology Etiopathogenesis Treatment |
| isfreeaccess_bool |
false |
| container_title |
Current Review of Pain |
| authorswithroles_txt_mv |
Chiappedi, Matteo @@aut@@ Balottin, Umberto @@aut@@ |
| publishDateDaySort_date |
2014-02-13T00:00:00Z |
| hierarchy_top_id |
SPR023001666 |
| id |
SPR023009993 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR023009993</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230520013011.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201006s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s11916-014-0404-9</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR023009993</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s11916-014-0404-9-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Chiappedi, Matteo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Medication Overuse Headache in Children and Adolescents</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Medication overuse headache can be described as a chronic headache, presenting 15 or more days per month, in a patient who abuses symptomatic drugs. It has been called an unrecognized epidemic; this is in part true for adults, but is certainly so for children and adolescents. This paper reviews existing data concerning epidemiology, etiopathogenesis and treatment options, with a focus on pediatric age. This leads to evidence of a relevant number of still unanswered questions and some possible strategies to help children and adolescents with this disabling disorder.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medication overuse headache</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Child</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adolescent</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chronic headache</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Epidemiology</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Etiopathogenesis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Treatment</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Balottin, Umberto</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Current Review of Pain</subfield><subfield code="d">Current Medicine Group, 1998</subfield><subfield code="g">18(2014), 4 vom: 13. Feb.</subfield><subfield code="w">(DE-627)SPR023001666</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:18</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:4</subfield><subfield code="g">day:13</subfield><subfield code="g">month:02</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s11916-014-0404-9</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_252</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">18</subfield><subfield code="j">2014</subfield><subfield code="e">4</subfield><subfield code="b">13</subfield><subfield code="c">02</subfield></datafield></record></collection>
|
| author |
Chiappedi, Matteo |
| spellingShingle |
Chiappedi, Matteo misc Medication overuse headache misc Child misc Adolescent misc Chronic headache misc Epidemiology misc Etiopathogenesis misc Treatment Medication Overuse Headache in Children and Adolescents |
| authorStr |
Chiappedi, Matteo |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)SPR023001666 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
Medication Overuse Headache in Children and Adolescents Medication overuse headache (dpeaa)DE-He213 Child (dpeaa)DE-He213 Adolescent (dpeaa)DE-He213 Chronic headache (dpeaa)DE-He213 Epidemiology (dpeaa)DE-He213 Etiopathogenesis (dpeaa)DE-He213 Treatment (dpeaa)DE-He213 |
| topic |
misc Medication overuse headache misc Child misc Adolescent misc Chronic headache misc Epidemiology misc Etiopathogenesis misc Treatment |
| topic_unstemmed |
misc Medication overuse headache misc Child misc Adolescent misc Chronic headache misc Epidemiology misc Etiopathogenesis misc Treatment |
| topic_browse |
misc Medication overuse headache misc Child misc Adolescent misc Chronic headache misc Epidemiology misc Etiopathogenesis misc Treatment |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Current Review of Pain |
| hierarchy_parent_id |
SPR023001666 |
| hierarchy_top_title |
Current Review of Pain |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)SPR023001666 |
| title |
Medication Overuse Headache in Children and Adolescents |
| ctrlnum |
(DE-627)SPR023009993 (SPR)s11916-014-0404-9-e |
| title_full |
Medication Overuse Headache in Children and Adolescents |
| author_sort |
Chiappedi, Matteo |
| journal |
Current Review of Pain |
| journalStr |
Current Review of Pain |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2014 |
| contenttype_str_mv |
txt |
| author_browse |
Chiappedi, Matteo Balottin, Umberto |
| container_volume |
18 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Chiappedi, Matteo |
| doi_str_mv |
10.1007/s11916-014-0404-9 |
| author2-role |
verfasserin |
| title_sort |
medication overuse headache in children and adolescents |
| title_auth |
Medication Overuse Headache in Children and Adolescents |
| abstract |
Abstract Medication overuse headache can be described as a chronic headache, presenting 15 or more days per month, in a patient who abuses symptomatic drugs. It has been called an unrecognized epidemic; this is in part true for adults, but is certainly so for children and adolescents. This paper reviews existing data concerning epidemiology, etiopathogenesis and treatment options, with a focus on pediatric age. This leads to evidence of a relevant number of still unanswered questions and some possible strategies to help children and adolescents with this disabling disorder. |
| abstractGer |
Abstract Medication overuse headache can be described as a chronic headache, presenting 15 or more days per month, in a patient who abuses symptomatic drugs. It has been called an unrecognized epidemic; this is in part true for adults, but is certainly so for children and adolescents. This paper reviews existing data concerning epidemiology, etiopathogenesis and treatment options, with a focus on pediatric age. This leads to evidence of a relevant number of still unanswered questions and some possible strategies to help children and adolescents with this disabling disorder. |
| abstract_unstemmed |
Abstract Medication overuse headache can be described as a chronic headache, presenting 15 or more days per month, in a patient who abuses symptomatic drugs. It has been called an unrecognized epidemic; this is in part true for adults, but is certainly so for children and adolescents. This paper reviews existing data concerning epidemiology, etiopathogenesis and treatment options, with a focus on pediatric age. This leads to evidence of a relevant number of still unanswered questions and some possible strategies to help children and adolescents with this disabling disorder. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_73 GBV_ILN_252 |
| container_issue |
4 |
| title_short |
Medication Overuse Headache in Children and Adolescents |
| url |
https://dx.doi.org/10.1007/s11916-014-0404-9 |
| remote_bool |
true |
| author2 |
Balottin, Umberto |
| author2Str |
Balottin, Umberto |
| ppnlink |
SPR023001666 |
| mediatype_str_mv |
c |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.1007/s11916-014-0404-9 |
| up_date |
2024-07-03T16:17:06.115Z |
| _version_ |
1803575284061962240 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR023009993</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230520013011.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201006s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s11916-014-0404-9</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR023009993</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s11916-014-0404-9-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Chiappedi, Matteo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Medication Overuse Headache in Children and Adolescents</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Medication overuse headache can be described as a chronic headache, presenting 15 or more days per month, in a patient who abuses symptomatic drugs. It has been called an unrecognized epidemic; this is in part true for adults, but is certainly so for children and adolescents. This paper reviews existing data concerning epidemiology, etiopathogenesis and treatment options, with a focus on pediatric age. This leads to evidence of a relevant number of still unanswered questions and some possible strategies to help children and adolescents with this disabling disorder.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medication overuse headache</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Child</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adolescent</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chronic headache</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Epidemiology</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Etiopathogenesis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Treatment</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Balottin, Umberto</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Current Review of Pain</subfield><subfield code="d">Current Medicine Group, 1998</subfield><subfield code="g">18(2014), 4 vom: 13. Feb.</subfield><subfield code="w">(DE-627)SPR023001666</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:18</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:4</subfield><subfield code="g">day:13</subfield><subfield code="g">month:02</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s11916-014-0404-9</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_252</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">18</subfield><subfield code="j">2014</subfield><subfield code="e">4</subfield><subfield code="b">13</subfield><subfield code="c">02</subfield></datafield></record></collection>
|
| score |
7.3993473 |